Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Dixon | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
James D. Carlson | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | 1 years |
Alan K. Copa | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
Mark Ubert | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | 1 years |
Steve Unwin | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
Douglas Turk | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
David Coggin | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
Katherine Cloninger | F | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | - |
Lona Sheeran | F | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | 2 years |
Ardheshir Khadang | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | 8 years |
Christopher Both | M | - |
PRACS Institute Ltd.
PRACS Institute Ltd. Miscellaneous Commercial ServicesCommercial Services A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa. | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 11 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John F. Pottier
- Personal Network